aims to create collaboration ties between academics, researchers, regulators.
Genomic Medicine Alliance Working Groups
Οne of the key goals of the Genomic Medicine Alliance is to encourage and catalyze multidisciplinary collaborative research between partner institutions and scientists, particularly from emerging countries and to establish collaboration ties among research organizations, clinical entities and regulatory agencies in areas related to genomic medicine.
Genome Informatics
The National/Ethnic Mutation Databases are mutation depositories, recording extensive information over the described genetic heterogeneity of an ethnic group or population.
Genomics & Pharmacogenomics
We wish to focus on severe drug-induced adverse events, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug-induced liver injury.
Public Health Genomics
In the post-genomic era, we are witnessing significant advances in the functional decipherment of the human genome sequence that have been made possible by new technological developments in the field of genomic medicine.
Health Economics
Economic analysis allows healthcare decision makers to make resource allocation decisions, by performing cost-benefit analysis of the various interventions. Such analyses are important in the area of pharmacogenomics.